Introduction Plasma biomarkers—cost effective, non‐invasive indicators of Alzheimer's
disease (AD) and related disorders (ADRD)—have largely been studied in clinical research …

Background Suboptimal nutritional status is considered a modifiable risk factor for
Alzheimer's disease (AD). Identification of nutritional biomarker levels that are related to …

Objectives To investigate the impact of a six-month multi-ingredient nutrition supplement
intervention (Smartfish®), containing omega-3 polyunsaturated fatty acids (PUFAs), vitamin …

INTRODUCTION Preclinical Alzheimer's disease (AD) affects a significant proportion of
cognitively unimpaired (CU) older adults. Currently, blood‐based biomarkers detect very …

Background Many epidemiological studies indicate a clear link between nutrition and
Alzheimer's Disease (AD). Several nutrient deficiencies have been shown to be risk factors …

The dynamic phase of preclinical Alzheimer's disease, as characterised by accumulating
cortical amyloid-β (Aβ), is a window of opportunity for Aβ lowering therapies to have greater …

Background. Omega-3 (n-3) and omega-6 (n-6) polyunsaturated fatty acids (PUFAs) may
have different effects on cognitive health due to their anti-or pro-inflammatory properties …

Alzheimer's disease (AD) risk increases with age and lacks efficacious pharmacological
options. Summaries of the existing evidence reveal an association between Mediterranean …

Background: Whether multiple nutritional deficiencies have a synergic effect on mobility loss
remains unknown. This study aims to evaluate associations between multi-nutritional deficits …

The ApoE4 allele is the most well-studied genetic risk factor for Alzheimer's disease, a
condition that is increasing in prevalence and remains without a cure. Precision nutrition …